Positron emission tomography imaging in nonmalignant thoracic disorders
References (242)
- et al.
Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: Potential for error in interpretation
- et al.
18F FDG uptake in the large arteries: A correlation study with the atherogenic risk factors
- et al.
18F-FDG Uptake in the anterior mediastinum. Physiologic thymic uptake or disease?
Clin Positron Imaging
(2000) - et al.
FGD PET in a patient with pseudofractures from osteomalacia
Rev Esp Med Nucl
(2002) - et al.
The solitary pulmonary nodule
Radiol Clin North Am
(2002) - et al.
Likelihood of malignancy in a solitary pulmonary nodule — Comparison of Bayesian analysis and results of FDG-PET scan
Chest
(1997) Bronchoscopic diagnosis of solitary pulmonary nodules and lung masses in the absence of endobronchial abnormality
Chest
(1996)- et al.
Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules: Potential role in evaluation and management
Chest
(1993) - et al.
Evaluation of pulmonary lesions with FDG-PET: Comparison of findings in patients with and without a history of prior malignancy
Chest
(1996) - et al.
Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET)
J Thorac Cardiovasc Surg
(1995)
PET imaging in oncology
Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B
Blood
(1998)
Whole-body PET: Physiological and artifactual fluorodeoxyglucose accumulations
J Nucl Med
(1996)
18-FDG uptake due to benign pathology
Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine
Eur J Nucl Med
(1999)
Fluorine-18 deoxyglucose and false-positive results: A major problem in the diagnostics of oncological patients
Eur J Nucl Med
(1996)
Pitfalls in oncologic diagnosis with FDG PET imaging: Physiologic and benign variants
Radiographics
(1999)
To AC or not to AC: That is the question
J Nucl Med
(1999)
Untreated lung cancer: Quantification of systematic distortion of tumor size and shape on non-attenuation corrected 2-[fluorine-18]fluoro-2-deoxy-d-glucose PET scans
Radiology
(1996)
Whole-body positron emission tomography in clinical oncology: Comparison between attenuation corrected and uncorrected images
Eur J Nucl Med
(1997)
Lesion-to-background ratio in nonattenuation-corrected whole-body FDG PET images
J Nucl Med
(1998)
Attenuation correction in whole-body FDG oncological studies: The role of statistical reconstruction
Eur J Nucl Med
(1999)
Role of attenuation correction for fluorine-18 fluorodeoxyglucose positron emission tomography in the primary staging of malignant lymphoma
Eur J Nucl Med
(1999)
Effect of attenuation correction on lesion detectability in FDG PET of breast cancer
J Nucl Med
(1999)
Impact of attenuation correction on the accuracy of FDG-PET in patients with abdominal tumors: A free-response ROC analysis
Eur J Nucl Med
(2000)
Coincidence detection FDG PET in the management of oncological patients: Attenuation correction versus non-attenuation correction
Nucl Med Commun
(2001)
Whole-body positron emission tomography for oncology imaging using singles transmission scanning with segmentation and ordered subsets-expectation maximization (OS-EM) reconstruction
Eur J Nucl Med
(1998)
A method for postinjection PET transmission measurements with a rotating source
J Nucl Med
(1988)
Singles transmission in volume-imaging PET with a 137Cs source
Phys Med Biol
(1995)
Singles transmission scans performed postinjection for quantitative whole body PET imaging
IEEE Trans Nucl Sci
(1997)
Simultaneous emission and transmission (SET) scanning in neurological PET studies
J Comput Assist Tomogr
(1997)
Accelerated image reconstruction using ordered subsets of projection data
IEEE Trans Med Imag
(1994)
Noise reduction in oncology FDG PET images by iterative reconstruction: A quantitative assessment
J Nucl Med
(2001)
Clinical evaluation of processing techniques for attenuation correction with 137Cs in whole body PET imaging
J Nucl Med
(1999)
Effects of iterative reconstruction on image contrast and lesion detection in gamma camera coincidence imaging in lung and breast cancers
Nucl Med Commun
(2002)
Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-d-glucose uptake in positron emission tomography studies of normal humans
Eur J Nucl Med
(1993)
The association between chronic obstructive pulmonary disease and right ventricle uptake in whole body PET scans
F-18 FDG uptake in the large arteries: A new observation
Clin Nucl Med
(2001)
Detection of atherosclerosis using novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG)
Nucl Med Commun
(2001)
Noninvasive serial monitoring of atherosclerotic progression and regression with FDG-PET in a rabbit model
J Nucl Med
(2000)
FDG uptake in chronic superior vena cava thrombus on positron emission tomographic imaging
Clin Nucl Med
(2001)
F-18 FDG uptake in benign esophageal disease
Clin Nucl Med
(1999)
Normal thymic uptake of FDG on PET imaging
Clin Nucl Med
(1996)
Increased metabolic activity in the thymus gland studied with 18F-FDG PET: Age dependency and frequency after chemotherapy
J Nucl Med
(2001)
Normal thymic uptake of 2-deoxy-2[F-18]fluoro-d-glucose
Clin Nucl Med
(1999)
Skeletal muscle uptake of fluorine-18-FDG: Effect of oral diazepam
J Nucl Med
(1996)
In vivo effects of insulin on tumor and skeletal muscle glucose metabolism in patients with lymphoma
Cancer
(1994)
Unilateral diaphragmatic crus uptake on FDG positron emission tomographic imaging
Clin Nucl Med
(2001)
Demonstration of excessive metabolic activity of thoracic and abdominal muscles on FDG-PET in patients with COPD
J Nucl Med
(2002)
Quantitative PET imaging of bone marrow glucose metabolic response to hematopoietic cytokines
J Nucl Med
(1995)
Cited by (199)
FDG avid solitary pulmonary nodule mimicking lung cancer
2022, Radiology Case ReportsA Case of Nodal Anthracosis Presenting as PET-Positive Mediastinal and Hilar Lymphadenopathies
2020, Mayo Clinic ProceedingsDifferences in lung injury after IMRT or proton therapy assessed by <sup>18</sup>FDG PET imaging
2018, Radiotherapy and Oncology
Copyright © 2002 Elsevier Inc. All rights reserved.